Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 4:44 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 506879 | NSE: GUJTHEM

Gujarat Themis Biosyn Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹238.14Fairly Valued by 3.59%vs CMP ₹247.00

P/E (56.3) × ROE (21.7%) × BV (₹24.30) × DY (0.27%)

₹87.65Overvalued by 64.51%vs CMP ₹247.00
MoS: -181.8% (Negative)Confidence: 66/100 (Moderate)Models: 1 Fair, 9 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹242.5020%Fair (-1.8%)
Graham NumberEarnings₹48.9414%Over (-80.2%)
Earnings PowerEarnings₹36.8112%Over (-85.1%)
DCFCash Flow₹45.7612%Over (-81.5%)
Net Asset ValueAssets₹24.316%Over (-90.2%)
EV/EBITDAEnterprise₹48.548%Over (-80.3%)
Dividend DiscountDividends₹16.528%Over (-93.3%)
Earnings YieldEarnings₹43.806%Over (-82.3%)
ROCE CapitalReturns₹145.448%Over (-41.1%)
Revenue MultipleRevenue₹20.785%Over (-91.6%)
Consensus (10 models)₹87.65100%Overvalued
Key Drivers: Wide model spread (₹17–₹243) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 1.8%

*Investments are subject to market risks

Investment Snapshot

64
Gujarat Themis Biosyn Ltd scores 64/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health88/100 · Strong
ROCE 27.3% ExcellentROE 21.7% ExcellentD/E 0.00 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money60/100 · Moderate
FII holding up 0.05% (6mo) Slight increasePromoter holding at 70.9% Stable
Earnings Quality50/100 · Moderate
OPM contracting (51% → 46%) DecliningWorking capital: 46 days (improving) Efficient
Quarterly Momentum40/100 · Moderate
Revenue (4Q): 2% YoY FlatProfit (4Q): -11% YoY Declining
Industry Rank75/100 · Strong
P/E 56.3 vs industry 53.8 In-lineROCE 27.3% vs industry 16.4% Above peersROE 21.7% vs industry 15.2% Above peers3Y sales CAGR: 10% Moderate

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 4:44 am

Market Cap 2,692 Cr.
Current Price 247
Intrinsic Value₹87.65
High / Low 479/222
Stock P/E56.3
Book Value 24.3
Dividend Yield0.27 %
ROCE27.3 %
ROE21.7 %
Face Value 1.00
PEG Ratio30.74

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Gujarat Themis Biosyn Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Gujarat Themis Biosyn Ltd 2,692 Cr. 247 479/22256.3 24.30.27 %27.3 %21.7 % 1.00
Orchid Pharma Ltd 2,634 Cr. 519 899/471101 2510.00 %8.07 %8.21 % 10.0
Gufic BioSciences Ltd 2,895 Cr. 289 409/26857.3 62.70.03 %13.2 %12.3 % 1.00
Bliss GVS Pharma Ltd 2,427 Cr. 229 244/10522.0 1070.22 %11.7 %8.36 % 1.00
Advanced Enzyme Technologies Ltd 2,981 Cr. 266 367/25220.7 1331.95 %13.1 %9.54 % 2.00
Industry Average19,815.15 Cr1,053.8453.84201.200.39%16.35%15.16%6.10

All Competitor Stocks of Gujarat Themis Biosyn Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 28285040394239354038364243
Expenses 16132623212120192122222122
Operating Profit 12142417182119151916142121
OPM % 43%52%47%42%46%50%48%44%48%42%39%49%49%
Other Income 2211111001010
Interest 0000000000001
Depreciation 1111111121234
Profit before tax 13162417182118141716121917
Tax % 26%25%26%26%26%24%26%26%25%25%25%24%26%
Net Profit 1012181313161311131291412
EPS in Rs 0.901.071.631.151.191.461.210.971.191.100.831.311.14

Last Updated: March 3, 2026, 9:22 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 27, 2026, 6:55 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 3031333639418591115148170151159
Expenses 24252730333453505775918187
Operating Profit 67666732405874797072
OPM % 21%21%19%17%16%18%37%45%51%50%46%46%45%
Other Income 0-000022347423
Interest 1000001110001
Depreciation 11111112234510
Profit before tax 55555831415977796664
Tax % 0%0%0%10%20%22%24%26%26%25%25%26%
Net Profit 55544624304458594948
EPS in Rs 0.420.420.420.400.360.592.172.774.005.325.434.484.38
Dividend Payout % 0%0%0%0%0%0%10%0%37%14%12%15%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)0.00%0.00%-20.00%0.00%50.00%300.00%25.00%46.67%31.82%1.72%-16.95%
Change in YoY Net Profit Growth (%)0.00%0.00%-20.00%20.00%50.00%250.00%-275.00%21.67%-14.85%-30.09%-18.67%

Gujarat Themis Biosyn Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

No data available for the compounded sales growth chart.

Balance Sheet

Last Updated: February 1, 2026, 2:56 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 777777777771111
Reserves -13-8-31511356396142194237254
Borrowings 963416851033071
Other Liabilities 139898814141817172241
Total Liabilities 1615152120336488122166221301377
Fixed Assets 11109111115171919333841162
CWIP 00000102132191184132
Investments 0000000000000
Other Assets 555111017476790113927682
Total Assets 1615152120336488122166221301377

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 43436111140396491
Cash from Investing Activity + -0-0-1-3-1-6-3-2-30-20-55-112
Cash from Financing Activity + -3-3-3-0-452-5-14-13-926
Net Cash Flow 1-1-0010-03-4605
Free Cash Flow 42305-5-372616-10-25
CFO/OP 68%44%73%57%99%25%24%51%94%81%107%154%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-3.001.003.002.005.001.0024.0035.0057.0074.0076.0040.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 152824712652875980445876
Inventory Days 781941442552013375
Days Payable 9472408414513199218
Cash Conversion Cycle 15282471-8445241119189114-7-67
Working Capital Days -152-76-70-42-43-584280155915046
ROCE %208%121%81%55%42%45%84%67%67%61%45%27%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 75.00%75.00%75.00%70.87%70.87%70.87%70.87%70.87%70.87%70.87%70.87%70.87%
FIIs 0.01%0.01%0.01%0.86%1.05%1.44%1.49%1.42%1.91%2.51%2.95%1.96%
DIIs 0.03%0.03%0.03%0.04%0.82%1.18%1.17%1.17%1.17%1.17%1.17%1.17%
Public 24.95%24.95%24.96%28.23%27.26%26.52%26.47%26.55%26.05%25.44%25.01%26.00%
No. of Shareholders 16,80417,37319,84628,65529,57630,28031,27130,93430,67328,94528,31927,325

Shareholding Pattern Chart

No. of Shareholders

Gujarat Themis Biosyn Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Quant Value Fund 258,000 0.5 7.95N/AN/AN/A

ROCE / ROE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.005.005.005.00
Basic EPS (Rs.) 4.488.1439.9030.0320.77
Diluted EPS (Rs.) 4.488.1439.9030.0320.77
Cash EPS (Rs.) 4.978.6341.6731.5621.96
Book Value[Excl.RevalReserv]/Share (Rs.) 22.7927.72102.6671.1148.14
Book Value[Incl.RevalReserv]/Share (Rs.) 22.7927.72102.6671.1148.14
Dividend / Share (Rs.) 0.671.005.4011.001.65
Revenue From Operations / Share (Rs.) 13.8423.38102.5479.0562.33
PBDIT / Share (Rs.) 6.5411.4455.2342.7429.42
PBIT / Share (Rs.) 6.0510.9553.4641.2028.23
PBT / Share (Rs.) 6.0110.9253.3240.6328.14
Net Profit / Share (Rs.) 4.488.1439.9030.0320.77
PBDIT Margin (%) 47.2648.9353.8654.0647.19
PBIT Margin (%) 43.7046.8552.1352.1245.28
PBT Margin (%) 43.4646.7151.9951.3945.14
Net Profit Margin (%) 32.3434.8338.9137.9833.32
Return on Networth / Equity (%) 19.6329.3738.8642.2243.14
Return on Capital Employeed (%) 23.4738.8251.4156.8256.61
Return On Assets (%) 16.1826.7534.8535.6134.19
Long Term Debt / Equity (X) 0.110.000.000.000.00
Total Debt / Equity (X) 0.120.000.000.000.00
Asset Turnover Ratio (%) 0.570.871.031.091.19
Current Ratio (X) 2.532.943.984.574.00
Quick Ratio (X) 2.282.743.033.893.62
Inventory Turnover Ratio (X) 36.022.862.272.462.61
Dividend Payout Ratio (NP) (%) 3.7211.6621.0523.317.94
Dividend Payout Ratio (CP) (%) 3.3511.0020.1522.177.51
Earning Retention Ratio (%) 96.2888.3478.9576.6992.06
Cash Earning Retention Ratio (%) 96.6589.0079.8577.8392.49
Interest Coverage Ratio (X) 195.82362.56399.8175.01329.82
Interest Coverage Ratio (Post Tax) (X) 134.99259.13289.8353.70233.87
Enterprise Value (Cr.) 3084.712869.27987.92579.63268.24
EV / Net Operating Revenue (X) 20.4616.906.635.052.96
EV / EBITDA (X) 43.2834.5312.319.336.28
MarketCap / Net Operating Revenue (X) 20.3416.946.695.153.27
Retention Ratios (%) 96.2788.3378.9476.6892.05
Price / BV (X) 12.3514.296.695.734.23
Price / Net Operating Revenue (X) 20.3416.946.695.153.27
EarningsYield 0.010.020.050.070.10

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Gujarat Themis Biosyn Ltd. is a Public Limited Listed company incorporated on 11/12/1981 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1981PLC004878 and registration number is 004878. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 150.80 Cr. and Equity Capital is Rs. 10.90 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
PharmaceuticalsPlot NO. 69-C, G.I.D.C., Valsad District Gujarat 396195Contact not found
Management
NamePosition Held
Dr. Dinesh S PatelNon Executive Chairman
Dr. Sachin D PatelManaging Director
Mr. Hitesh D GajariaIndependent Director
Mr. K G AnanthakrishnanIndependent Director
Mr. Nihar ParikhIndependent Director
Mr. Siddharth Y KusumgarIndependent Director
Mrs. Kirandeep Kaur MadanIndependent Director

FAQ

What is the intrinsic value of Gujarat Themis Biosyn Ltd and is it undervalued?

As of 10 April 2026, Gujarat Themis Biosyn Ltd's intrinsic value is ₹87.65, which is 64.51% lower than the current market price of ₹247.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (21.7 %), book value (₹24.3), dividend yield (0.27 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Gujarat Themis Biosyn Ltd?

Gujarat Themis Biosyn Ltd is trading at ₹247.00 as of 10 April 2026, with a FY2026-2027 high of ₹479 and low of ₹222. The stock is currently near its 52-week low. Market cap stands at ₹2,692 Cr..

How does Gujarat Themis Biosyn Ltd's P/E ratio compare to its industry?

Gujarat Themis Biosyn Ltd has a P/E ratio of 56.3, which is above the industry average of 53.84. The premium over industry average may reflect growth expectations or speculative interest.

Is Gujarat Themis Biosyn Ltd financially healthy?

Key indicators for Gujarat Themis Biosyn Ltd: ROCE of 27.3 % indicates efficient capital utilization; ROE of 21.7 % shows strong shareholder returns. Dividend yield is 0.27 %.

Is Gujarat Themis Biosyn Ltd profitable and how is the profit trend?

Gujarat Themis Biosyn Ltd reported a net profit of ₹49 Cr in Mar 2025 on revenue of ₹151 Cr. Compared to ₹44 Cr in Mar 2022, the net profit shows an improving trend.

Does Gujarat Themis Biosyn Ltd pay dividends?

Gujarat Themis Biosyn Ltd has a dividend yield of 0.27 % at the current price of ₹247.00. The company pays dividends, though the yield is modest.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Gujarat Themis Biosyn Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports